Health systems consulting
SCIDaR facilitates transformative community-driven solutions that build vibrant, resilient, and healthy communities.
Vaccine Supply Chain Revamp
SCIDaR worked with Kano state and donor partners to develop and implement a suite of supply chain interventions. On this project, the team was able to deploy weekly vaccine stock performance dashboards at both LGA and ward levels to guide timely vaccine stock replenishment and other logistics decisions. Also, we rolled out a new vaccine distribution system which was streamlined to enable direct delivery of vaccines from state satellites stores to equipped health facilities.
Polio Outbreak Response Africa
The polio disease epidemic hit West and Central Africa in 2004 and in response Africa launched the largest immunization campaigns in the world. With the interventions of donors and the African government, on the 25th of August 2020, after four (4) years without a single case of wild polio, the African region was certified free of wild poliovirus and the decades of extraordinary investment has paid off.
Borno Polio Outbreak Response
The Borno Polio Outbreak Response team supports vaccination in all partially accessible and inaccessible settlements and ensures at least 90% of these settlements are reached by security access teams for vaccination with bOPV. Also, the team supports Borno EOC to consolidate all PEI datasets, use data for action and build the capacity of state staff on the EOC M&E team.
RI Financial Management System Strengthening
SCIDaR led the rollout of a revised financial management system to ensure effective and transparent utilization of routine immunization funds in 6 Nigerian states; Bauchi, Borno, Kaduna, Kano, Sokoto and Yobe States. On this project, we successfully established a direct electronic disbursement system managed by the State to enable prompt receipt of funds by end-users at all levels, supported the States, LGAs & health facilities to establish dedicated bank accounts to enable direct end-user access to RI funds and the internal audit units of State PHC Agencies to validate retired funds and flag irregularities to the leadership team.
Investing in Innovation (i3) project
On the i3 project, SCIDaR partners with Salient Advisory, Southbridge A&I, SBCAfritech, IMPACT Lab, and Co-creation Hub. The i3 project is a $7 million pan-African support program for health start-ups that bring quality health products closer to patients at affordable prices. Within the next two (2) years, sixty (60) promising African health start-ups will get grants and access to market support to expand and have a greater impact on health. A special focus is on African Innovators with ground-breaking solutions to the health supply chain challenges in Africa.
Frontier Health Markets Engage (FHM)
Solina is part of a network of implementing partners on the USAID-funded Frontier Health Markets (FHM) Engage project led by Chemonics international. FHM Engage is a global cooperative agreement to provide technical support to local actors to improve access to family planning (FP), and maternal, neonatal, and child health (MNCH) outcomes by strengthening the private sector markets in their twenty-four (24) priority countries (including Nigeria).
Polio Nigeria Project
Nigeria, and by extension Africa, is officially wild poliovirus (WPV) free, thanks to large, ongoing investments and efforts by Nigeria and GPEI partners. The last incidence of WPV was discovered in Nigeria in August 2016. However, outbreaks of circulating vaccine-derived poliovirus 2 (cVDPV2) have recently emerged in various countries, including Nigeria. In this one-year project, SCIDaR provides technical assistance to the national and state EOCs/SPHCDAs in their response to the cVDPV2 transmission, building on our experience supporting polio programmes in Borno and Yobe states.
Antenatal Risk Stratification (ARS) Project
Solina has teamed up with Helium Health to deploy an antenatal risk stratification (ARS) tool in Lagos, Kano, and Akwa Ibom States in Nigeria. The project’s objective is to enhance knowledge about individualised pregnancy risk levels and facilitate early decision-making concerning the need for appropriate care and the ideal location to receive healthcare, thereby addressing the first and second phases of delays.
Helium Health and Solina will adapt an existing solution to support ARS by combining patient demographic, behavioural, and obstetric clinical information to predict and communicate antenatal risk levels to pregnant women via HeliumDoc and HeliumEMR platforms.
